Cardiovascular involvement in COVID-19

Authors

  • Valenzuela-Rodríguez Germán Clínica Delgado-AUNA
  • Percy Amado-Tineo Hospital Nacional Edgardo Rebagliati Martins- EsSalud

DOI:

https://doi.org/10.36393/spmi.v33i2.522

Keywords:

SARS-CoV-2, COVID-19, cardiovascular, myocardial injury, myocarditis, cardiomyopathies, heart failure, acute coronary syndromes, arrhythmias, thromboembolism

Abstract

Cardiovascular compromise among COVID-19 patients, especially in the subpopulation with cardiovascular risk factors, is associated with severity of disease and a higher mortality in some case-series.The most clearly described pathophysiological mechanisms are direct myocardial injury and the process associated with systemic inflammation. Cardiovascular manifestations are diverse and include myocardial injury, myocarditis,
cardiomyopathies, heart failure, acute coronary syndromes, arrhythmias, thromboembolic events.
Moreover, we must consider the adverse effects of medications used to treat the viral infection.

Downloads

Download data is not yet available.

Downloads

Published

2020-06-12

Issue

Vol. 33 No. 2 (2020)

Section

Tema de revisión

How to Cite

Cardiovascular involvement in COVID-19. (2020). Revista De La Sociedad Peruana De Medicina Interna, 33(2), 61-67. https://doi.org/10.36393/spmi.v33i2.522